The antibodies used in the remedy were also found to be largely neutralizing antibodies, capable of attacking other sites of the virus, according to Zhang Linqi, the lead scientist involved in the remedy and also a professor at Tsinghua University School of Medicine.
“Antibodies and vaccines are complementary to each other, and they have their role in preventing and treating diseases,” Zhang said in December 2021, interviewed through The Paper, a Chinese virtual media outlet.
In addition to this cocktail therapy, China has made progress in the emergence of COVID-19 over the past three years, the most recent being a nasal spray-based monoclonal antibody, F61.
Developed through Sinopharm, the pharmaceutical company guilty of generating the country’s inactivated COVID-19 vaccines, F61 approved the clinical trial on Nov. 28. It is also a broad-spectrum neutralizing antibody with a very active reaction against Omicron variants.
Together with the progression and production of other COVID-19 medications, they reduce the severity of symptoms and prevent hospitalization and death for others infected with COVID-19.
But initially, vaccinating other people is the most effective way to prevent the virus from mutating, as one expert at China’s Center for Disease Control and Prevention (CDC) put it.
In an interview with China Media Group in April 2021, Wang Huaqing, the CDC’s lead scientist for the vaccination plan, said China wants at least one billion people vaccinated to improve immune protection.
As of December 7, 2022, around 3450 million vaccines were administered and more than 228 million people over the age of 60 were fully vaccinated as of November 28, representing more than 86% of the general population at this age. group, according to the National Health Commission.
China is lately launching a crusade for booster shots for the time being, among the elderly.
Thanks to continued advances in vaccine development, China now has COVID-19 vaccines that can be given to others by injection, inhalation, and nasal spray.
It is also accelerating the progression of its messenger RNA vaccines, one of which was approved for emergency use in Indonesia in September.
https://news. cgtn. com/news/2022-12-17/-New-Approaches-Cómo-China-intensificó-sus-tratamientos-COVID-19-1fNYIqSorxS/index. html
SOURCE CGTN